None
Quote | Karyopharm Therapeutics Inc. (NASDAQ:KPTI)
Last: | $0.89 |
---|---|
Change Percent: | 0.82% |
Open: | $0.91 |
Close: | $0.89 |
High: | $0.9231 |
Low: | $0.8621 |
Volume: | 815,486 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
News | Karyopharm Therapeutics Inc. (NASDAQ:KPTI)
Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates PR Newswire Long-Term Follow-Up Data Signal Promising Progression-Free S...
Karyopharm to Participate at the Jefferies Global Healthcare Conference PR Newswire NEWTON, Mass. , May 29, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announ...
Message Board Posts | Karyopharm Therapeutics Inc. (NASDAQ:KPTI)
Subject | By | Source | When |
---|---|---|---|
Cara, Iovance, and Karyopharm among biotechs with no | dcaf7 | investorshub | 03/11/2023 2:28:46 PM |
Good news for Karyopharm. | dcaf7 | investorshub | 03/05/2023 3:00:58 PM |
znewcar1: Not a lot of Views an hour into it. $KPTI | znewcar1 | investorshangout | 11/04/2022 2:41:51 PM |
znewcar1: $KPTI 13% $5.1 HOD5.54 LOD4.33 what a Vee huge sel vol | znewcar1 | investorshangout | 11/04/2022 2:41:02 PM |
znewcar1: KPTI 19% v17,7M c14.38 f75,7M H14.73 morning pop >13 held14 | znewcar1 | investorshangout | 02/18/2022 10:07:28 PM |
News, Short Squeeze, Breakout and More Instantly...
Karyopharm Therapeutics Inc. Company Name:
KPTI Stock Symbol:
NASDAQ Market:
Karyopharm Therapeutics Inc. Website:
Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates PR Newswire Long-Term Follow-Up Data Signal Promising Progression-Free S...
Karyopharm to Participate at the Jefferies Global Healthcare Conference PR Newswire NEWTON, Mass. , May 29, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announ...